bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2023,
Volume and Issue:
unknown
Published: Nov. 17, 2023
Abstract
The
mutations
driving
cancer
are
being
increasingly
exposed
through
tumor-specific
genomic
data.
However,
differentiating
between
cancer-causing
driver
and
random
passenger
remains
challenging.
State-of-the-art
homology-based
predictors
contain
built-in
biases
often
ill-suited
to
the
intricacies
of
biology.
Protein
Language
Models
have
successfully
addressed
various
biological
problems
but
not
yet
been
tested
on
challenging
task
mutation
prediction
at
large
scale.
Additionally,
they
fail
offer
result
interpretation,
hindering
their
effective
use
in
clinical
settings.
AI-based
D2Deep
method
we
introduce
here
addresses
these
challenges
by
combining
two
powerful
elements:
i)
a
non-specialized
protein
language
model
that
captures
makeup
all
sequences
ii)
protein-specific
evolutionary
information
encompasses
functional
requirements
for
particular
protein.
relies
exclusively
sequence
information,
outperforms
state-of-the-art
intricate
epistatic
changes
throughout
caused
mutations.
These
correlate
with
known
setting
can
be
used
interpretation
results.
is
trained
balanced,
somatic
training
set
so
effectively
mitigates
related
hotspot
compared
techniques.
versatility
illustrated
its
performance
non-cancer
prediction,
where
most
variants
still
lack
consequences.
predictions
confidence
scores
available
via
https://tumorscope.be/d2deep
help
prioritization.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2023,
Volume and Issue:
unknown
Published: Sept. 30, 2023
Abstract
Short
Linear
Motifs
(SLiMs)
play
a
pivotal
role
in
mediating
interactions
between
intrinsically
disordered
proteins
and
their
binding
partners.
SLiMs
exhibit
sequence
degeneracy
undergo
regulation
through
post-translational
modifications,
including
phosphorylation.
The
flanking
regions
surrounding
the
core
motifs
also
exert
crucial
shaping
modes
of
interaction.
In
this
study,
we
aimed
to
integrate
biomolecular
simulations,
silico
high-throughput
mutational
scans,
biophysical
experiments
elucidate
structural
details
phospho-regulation
class
for
autophagy,
known
as
LC3
interacting
(LIRs).
As
case
investigated
interaction
optineurin
LC3B.
Optineurin
LIR
perfectly
exemplify
where
there
is
complex
interplay
different
phosphorylations
N-terminal
helical
region
be
disentangled.
Our
work
unveils
unexplored
upstream
motif
contributing
interface.
results
offer
an
atom-level
perspective
on
mechanisms
conformational
alterations
induced
by
phosphorylation
LC3B
recognition,
along
with
effects
mutations
background
phosphorylated
form
protein.
Additionally,
assessed
impact
disease-related
optineurin,
accounting
functional
features.
Notably,
established
approach
based
Microfluidic
Diffusional
Sizing
novel
method
investigate
affinity
target
proteins,
enabling
precise
measurements
dissociation
constant
selection
variants
identified
screening.
Overall,
our
provides
versatile
toolkit
characterize
other
LIR-containing
modulation
or
phospho-regulated
SLiMs,
thereby
advancing
understanding
important
cellular
processes.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2023,
Volume and Issue:
unknown
Published: Dec. 15, 2023
Abstract
Accurate
interpretation
of
genetic
variation
is
a
critical
step
towards
realizing
the
potential
precision
medicine.
Sequencing-based
tests
have
uncovered
vast
array
BRCA2
sequence
variants.
Due
to
limited
clinical,
familial
and/or
epidemiological
data,
thousands
variants
are
considered
be
uncertain
significance
(VUS).
To
determine
functional
impact
VUSs,
here
we
develop
AVENGERS:
Analysis
Variant
Effects
using
NGs
Enhance
Stratification,
utilizing
CRISPR-Cas9-based
saturation
genome
editing
(SGE)
in
humanized-mouse
embryonic
stem
cell
line.
We
categorized
nearly
all
possible
missense
single
nucleotide
(SNVs)
encompassing
C-terminal
DNA
binding
domain
BRCA2.
generated
function
scores
for
6270
SNVs,
covering
95.5%
SNVs
exons
15-26
spanning
residues
2479-3216,
including
1069
unique
VUS,
with
81%
and
14%
found
nonfunctional.
Our
classification
aligns
strongly
pathogenicity
data
from
ClinVar,
orthogonal
assays
computational
meta
predictors.
statistical
classifier
exhibits
92.2%
sensitivity
96%
specificity
distinguishing
clinically
benign
pathogenic
recorded
ClinVar.
Furthermore,
offer
proactive
evidence
617
being
non-functional
3396
demonstrated
by
on
growth
response
damaging
drugs
like
cisplatin
olaparib.
This
serves
as
valuable
resource
interpreting
unidentified
population
physicians
counselors
assessing
VUSs
patients.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2022,
Volume and Issue:
unknown
Published: Dec. 11, 2022
Abstract
S
-nitrosylation
is
a
post-translational
modification
in
which
nitric
oxide
(NO)
binds
to
the
thiol
group
of
cysteine,
generating
an
-nitrosothiol
(SNO)
adduct.
has
different
physiological
roles,
and
its
alteration
also
been
linked
growing
list
pathologies,
including
cancer.
SNO
can
affect
function
stability
proteins,
such
as
mitochondrial
chaperone
TRAP1.
Interestingly,
site
(C501)
TRAP1
proximity
another
cysteine
(C527).
This
feature
suggests
that
-nitrosylated
C501
could
engage
disulfide
bridge
with
C527
TRAP1,
resembling
well-known
ability
cysteines
resolve
vicinal
cysteines.
We
used
enhanced
sampling
simulations
in-vitro
biochemical
assays
address
structural
mechanisms
induced
by
S-
nitrosylation.
showed
induces
conformational
changes
proximal
favors
conformations
suitable
for
disulfide-bridge
formation.
explored
4172
known
proteins
using
high-throughput
analyses.
Furthermore,
we
carried
out
coarse-grain
44
account
protein
dynamics
resulted
identification
up
1248
examples
sense
redox
state
site,
opening
new
perspectives
on
biological
effects
switches.
In
addition,
devised
two
bioinformatic
workflows
(
https://github.com/ELELAB/SNO_investigation_pipelines
)
identify
or
accompanying
annotations.
Finally,
analyzed
mutations
tumor
suppressor
oncogenes
connection
switch
-nitrosylation.
classified
variants
neutral,
stabilizing,
destabilizing
respect
propensity
be
undergo
population-shift
mechanism.
The
methods
applied
here
provide
comprehensive
toolkit
future
studies
candidates,
variant
classification,
rich
data
source
research
community
NO
field.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2023,
Volume and Issue:
unknown
Published: Nov. 17, 2023
Abstract
The
mutations
driving
cancer
are
being
increasingly
exposed
through
tumor-specific
genomic
data.
However,
differentiating
between
cancer-causing
driver
and
random
passenger
remains
challenging.
State-of-the-art
homology-based
predictors
contain
built-in
biases
often
ill-suited
to
the
intricacies
of
biology.
Protein
Language
Models
have
successfully
addressed
various
biological
problems
but
not
yet
been
tested
on
challenging
task
mutation
prediction
at
large
scale.
Additionally,
they
fail
offer
result
interpretation,
hindering
their
effective
use
in
clinical
settings.
AI-based
D2Deep
method
we
introduce
here
addresses
these
challenges
by
combining
two
powerful
elements:
i)
a
non-specialized
protein
language
model
that
captures
makeup
all
sequences
ii)
protein-specific
evolutionary
information
encompasses
functional
requirements
for
particular
protein.
relies
exclusively
sequence
information,
outperforms
state-of-the-art
intricate
epistatic
changes
throughout
caused
mutations.
These
correlate
with
known
setting
can
be
used
interpretation
results.
is
trained
balanced,
somatic
training
set
so
effectively
mitigates
related
hotspot
compared
techniques.
versatility
illustrated
its
performance
non-cancer
prediction,
where
most
variants
still
lack
consequences.
predictions
confidence
scores
available
via
https://tumorscope.be/d2deep
help
prioritization.